energy-based therapy

DEVICE2 trials

Sponsors

Virginia Commonwealth University, Aclaris Therapeutics, Inc.

Conditions

Anxiety DisorderBreast CancerDepressionFatiguePainRosaceaSleep Disorders

Phase 3

Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer

CompletedNCT00902330

Virginia Commonwealth UniversityAnxiety Disorder, Breast Cancer, Depression +3

Start: 2009-04-30End: 2014-05-31Updated: 2015-11-23

Phase 4

Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea

CompletedNCT03380390

Aclaris Therapeutics, Inc.Rosacea

Start: 2017-12-04End: 2018-06-15Updated: 2019-09-04

Related Papers

Randomized sham controlled trial of cranial microcurrent stimulation for symptoms of depression, anxiety, pain, fatigue and sleep disturbances in women receiving chemotherapy for early-stage breast cancer.

2015-07-2321 citations